143 related articles for article (PubMed ID: 20101852)
1. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M
Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Capeller B; Caffier H; Sütterlin MW; Dietl J
Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
[TBL] [Abstract][Full Text] [Related]
3. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
4. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Halleen JM
Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
[TBL] [Abstract][Full Text] [Related]
5. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
Lyubimova NV; Pashkov MV; Tyulyandin SA; Gol'dberg VE; Kushlinskii NE
Bull Exp Biol Med; 2004 Jul; 138(1):77-9. PubMed ID: 15514730
[TBL] [Abstract][Full Text] [Related]
6. [TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
Dedkov AG; Boychuk SI; Stakhovsky EA; Kukushkina MN; Kovalchuk PA
Lik Sprava; 2015; (5-6):104-9. PubMed ID: 27089726
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate.
Martinetti A; Seregni E; Ripamonti C; Ferrari L; De Conno F; Miceli R; Pallotti F; Coliva A; Biancolini D; Bombardieri E
Int J Biol Markers; 2002; 17(4):253-8. PubMed ID: 12521129
[TBL] [Abstract][Full Text] [Related]
8. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
[TBL] [Abstract][Full Text] [Related]
9. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
[TBL] [Abstract][Full Text] [Related]
10. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Wu ZQ; Zhang Y; Xie E; Song WJ; Yang RX; Yan CJ; Zhang BF; Xu HG
PLoS One; 2016; 11(1):e0147554. PubMed ID: 26800211
[TBL] [Abstract][Full Text] [Related]
11. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
Nowak Z; Konieczna M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Zenger S; He W; Ek-Rylander B; Vassiliou D; Wedin R; Bauer H; Andersson G
Clin Exp Metastasis; 2011 Jan; 28(1):65-73. PubMed ID: 20967488
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Koizumi M; Takahashi S; Ogata E
Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
[TBL] [Abstract][Full Text] [Related]
14. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT
J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
16. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
Halleen JM; Alatalo SL; Janckila AJ; Woitge HW; Seibel MJ; Väänänen HK
Clin Chem; 2001 Mar; 47(3):597-600. PubMed ID: 11238321
[No Abstract] [Full Text] [Related]
17. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
[TBL] [Abstract][Full Text] [Related]
18. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay.
Halleen JM; Hentunen TA; Karp M; Käkönen SM; Pettersson K; Väänänen HK
J Bone Miner Res; 1998 Apr; 13(4):683-7. PubMed ID: 9556068
[TBL] [Abstract][Full Text] [Related]
19. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Chao TY; Wu YY; Janckila AJ
Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857
[TBL] [Abstract][Full Text] [Related]
20. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
